Latest Trabecular meshwork Stories
Combination Laser Platform Includes SLT and YAG for Treatment of Glaucoma and Cataract CLERMONT-FERRAND, France, July 9, 2014 /PRNewswire/ -- Quantel Medical today announced FDA 510(k)
A new layer in the human cornea — discovered by researchers at The University of Nottingham last year — plays a vital role in the structure of the tissue that controls the flow of fluid from the eye, research has shown.
Advanced Laser and Cataract Center is excited to announce the introduction of a new technology, Glaukos® Corporation’s iStent®, the first trabecular micro-bypass technology to gain
Inhibiting the protein, Grp94, could offer new treatment for the sight-robbing eye disease
A six-year collaboration between two faculty members of Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine has yielded new insight regarding the regulation of intraocular pressure (IOP) in glaucoma – an irreversible blinding disease that causes progressive visual impairment due to optic nerve damage and is the leading cause of blindness worldwide.
Glaucoma is the second leading cause of blindness.
Toxic Anterior Segment Syndrome (TASS) is a rare but sight threatening complication of cataract surgery.